Return to homepagePandemic Pact

TASK ORDER B03: EVALUATION OF ANTIVIRAL DRUG CANDIDATES AGAINST MPOX IN NHPS

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 75N93024D00005-0-759302500001-1

Grant search

Key facts

  • Disease

    mpox

  • Start & end year

    2025
    2026

  • Known Financial Commitments (USD)

    $1,250,576

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    GLORIA SIVKO

  • Research Location

    United States of America

  • Lead Research Institution

    BATTELLE CENTERS/PUB HLTH RES & EVALUATN

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Disease models

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

  • Mpox Research Priorities

    Therapeutics research, development and implementation

  • Mpox Research Sub Priorities

    Development of equitable, accessible, safe & effective therapeutics

Abstract

This contract provides for the development of new and refinement of non-human primate models of infectious diseases and may include evaluation of candidate countermeasures.